Myocath
The MyoCath is a disposable needle injection catheter used for the delivery of biologic solutions to a targeted treatment site within the myocardium, the inner wall of the heart. The MyoCath provides for multiple injections to a pre-determined needle insertion depth with a single core needle of 25 gauge diameter that can be advanced and retracted from the tip of the catheter. The MyoCath is intended for use with commercially available Becton-Dickinson 1 milliliter and 3 milliliter syringes. Although we hope to prove that MyoCell can be administered with a variety of different catheters, MyoCath has been specifically designed to be used for the delivery of MyoCell and has been used as the delivery mechanism in the majority of our clinical trials to date. We believe MyoCath has the potential to be approved for commercial use with MyoCell and has been tested for other commercial applications as well.
It is our hope that the MyoCath will prove to be more cost effective than, and as safe and effective as, other catheters at delivering MyoCell. Although the MyoCath has been designed for use with MyoCell, there are a number of other clinical therapies to treat heart disease currently in development by other companies that are delivered via the MyoCath including, gene, protein, cytokine and growth factor therapies. Three clinical trials have been initiated by biopharmaceutical companies and other institutions utilizing the MyoCath to deliver growth factors in an effort to increase blood supply to a damaged heart.
Candidate |
Proposed Use or Indication |
Status/Phase |
||
|---|---|---|---|---|
| MyoCath | Disposable needle injection catheter used for the delivery of biological solutions to the myocardium. | Used in European Phase II clinical trials of MyoCell; used in Phase I clinical trials of MyoCell |